Negotiated pricing agreements have lowered costs and will improve access to quality treatment for people living with HIV New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic,...
National HIV treatment programs are preparing for big shifts in their national treatment guidelines and patient regimens. The World Health Organization’s (WHO) 2016 guidelines included a number of antiretroviral (ARV) medications that are more effective, tolerable and...
Clinton Health Access Initiative, Inc. Policy Update: July 14, 2017 STATEMENT The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives, reducing the burden of disease, and strengthening integrated health systems in...
As we recognize World Hepatitis Day this year, there is hope for millions of people living with chronic hepatitis around the world. New, directly acting antiviral (DAA) medications are providing a cure to people infected with the disease. In Vietnam, one of the...
The Clinton Health Access Initiative (CHAI), with funding from Global Affairs Canada and the Norwegian Agency for Development Cooperation, partnered with the Nigerian Federal Ministry of Health, the National Primary Health Care Development Agency and the state...
Lesotho is a small, landlocked country surrounded by South Africa with a population of about 2 million people. It also has the second highest prevalence of HIV in the world, with 23 percent of the population infected. This high HIV prevalence is a key contributing...
The IKEA Foundation and the Clinton Health Access Initiative (CHAI) today announced two new four year grants totaling $16.8 million to continue work to reduce child mortality and provide access to lifesaving treatment for diarrhea and pneumonia in Madhya Pradesh,...
Market access agreements advance growing ACS-led effort to significantly improve cancer care in six sub-Saharan African countries The American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI) today announced two separate groundbreaking market...
Until recently, many low- and middle-income countries were not able to provide HIV treatment to all patients due to the high cost of medication and treatment was reserved for only the sickest individuals. Decisions about whether or not to initiate patients on...
CD4 cell count is an important diagnostic test to manage HIV-positive patients in low- and middle-income countries. CD4 testing is used to prioritize patients for treatment in settings where treatment is not accessible to all, monitor patients on treatment where viral...
